Evidence map›Paper›PMID 38509870›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Hypoxic Exosomal circPLEKHM1-Mediated Crosstalk between Tumor Cells and Macrophages Drives Lung Cancer Metastasis.

Dongliang Wang, Shuoer Wang, Mingming Jin, Yan Zuo, Jianpeng Wang, Ya Niu, Qian Zhou, Jiwei Chen, Xinru Tang, Wenxuan Tang and 7 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Rab27: Molecular switch of tumor exosome secretion (Review).International journal of molecular medicine · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dongliang WangDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Shuoer WangDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Mingming JinShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.
Yan ZuoDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Jianpeng WangDepartment of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, 150007, P. R. China.
Ya NiuDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Qian ZhouDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Jiwei ChenDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Xinru TangDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Wenxuan TangDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Xiyu LiuShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.
Hang YuDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Wangjun YanDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.
Huan-Huan WeiBio-med Big Data Center, Chinese Academy of Sciences Key Laboratory of Computational Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, Shanghai, 200031, P. R. China.
Gang HuangShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.
Shaoli SongDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Shuang TangDepartment of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.ORCID 0000-0002-3501-7836

Funding

National Key Research and Development Program of China 2020YFA0909000National Key Research and Development Program of China 2021YFA0805500National Natural Science Foundation of China 32270767National Natural Science Foundation of China 82072695National Natural Science Foundation of China 82072972National Natural Science Foundation of China 82127807National Natural Science Foundation of China 82272035National Natural Science Foundation of China U23A20465Shanghai Key Laboratory of Molecular Imaging 18DZ2260400
6 · The paper itself

Abstract

Intercellular communication often relies on exosomes as messengers and is critical for cancer metastasis in hypoxic tumor microenvironment. Some circular RNAs (circRNAs) are enriched in cancer cell-derived exosomes, but little is known about their ability to regulate intercellular communication and cancer metastasis. Here, by systematically analyzing exosomes secreted by non-small cell lung cancer (NSCLC) cells, a hypoxia-induced exosomal circPLEKHM1 is identified that drives NSCLC metastasis through polarizing macrophages toward to M2 type. Mechanistically, exosomal circPLEKHM1 promoted PABPC1-eIF4G interaction to facilitate the translation of the oncostatin M receptor (OSMR), thereby promoting macrophage polarization for cancer metastasis. Importantly, circPLEKHM1-targeted therapy significantly reduces NSCLC metastasis in vivo. circPLEKHM1 serves as a prognostic biomarker for metastasis and poor survival in NSCLC patients. This study unveils a new circRNA-mediated mechanism underlying how cancer cells crosstalk with macrophages within the hypoxic tumor microenvironment to promote metastasis, highlighting the importance of exosomal circPLEKHM1 as a prognostic biomarker and therapeutic target for lung cancer metastasis.

Indexed as

Carcinoma, Non-Small-Cell LungExosomesLung NeoplasmsMacrophagesRNA, CircularTumor MicroenvironmentAnimalsCell Line, TumorDisease Models, AnimalHumansMiceMice, NudeNeoplasm MetastasisRNA, CircularcircPLEKHM1exosomal circRNAhypoxiamacrophage polarizationmetastasisnon‐small cell lung cancers

Identifiers

PMID38509870
PMCPMC11165461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.